Cortical Abnormalities Associated With Pediatric and Adult Obsessive-Compulsive Disorder: Findings From the ENIGMA Obsessive-Compulsive Disorder Working Group

dc.contributor.authorAlonso, Pino
dc.contributor.authorENIGMA-OCD Working Group
dc.date.accessioned2020-12-09T14:33:50Z
dc.date.available2020-12-09T14:33:50Z
dc.date.issued2018
dc.date.updated2020-12-09T14:33:50Z
dc.description.abstractObjective: Brain imaging studies of structural abnormalities in OCD have yielded inconsistent results, partly due to limited statistical power, clinical heterogeneity, and methodological differences. Here, we perform meta- and mega-analyses comprising the largest study of cortical morphometry in OCD ever undertaken. Methods: T1-weighted MRI scans of 1905 OCD patients and 1760 healthy controls from 27 sites worldwide were processed locally using FreeSurfer to assess cortical thickness and surface area. Effect sizes for differences between patients and controls, and associations with clinical characteristics, were calculated using linear regression models controlling for age, sex, site, and intracranial volume. Results: In adult OCD patients versus controls, we found significantly lower surface area of the transverse temporal cortex and a thinner inferior parietal cortex. Medicated adult OCD patients also showed thinner cortices throughout the brain. In pediatric OCD patients versus controls, we found significantly thinner inferior and superior parietal cortices, but none of the regions analyzed showed significant differences in surface area. However, medicated pediatric OCD patients had lower surface area in frontal regions. Cohen's d effect sizes varied between −0.10 and −0.33. Conclusion The parietal cortex was consistently implicated both in adults and children with OCD. More widespread cortical thickness abnormalities were found in medicated adult OCD patients, and more pronounced surface area deficits (mainly in frontal regions) were found in medicated pediatric OCD patients. These cortical measures represent distinct morphological features and may be differentially affected during different stages of development and illness, and possibly moderated by disease profile and medication.
dc.format.extent10 p.
dc.format.mimetypeapplication/pdf
dc.identifier.idgrec687066
dc.identifier.issn0002-953X
dc.identifier.pmid29377733
dc.identifier.urihttps://hdl.handle.net/2445/172523
dc.language.isoeng
dc.publisherAmerican Psychiatric Association
dc.relation.isformatofVersió postprint del document publicat a: https://doi.org/10.1176/appi.ajp.2017.17050485
dc.relation.ispartofAmerican Journal of Psychiatry, 2018, vol. 175, num. 5, p. 453-462
dc.relation.urihttps://doi.org/10.1176/appi.ajp.2017.17050485
dc.rights(c) American Psychiatric Association, 2018
dc.rights.accessRightsinfo:eu-repo/semantics/openAccess
dc.sourceArticles publicats en revistes (Ciències Clíniques)
dc.subject.classificationNeurosi obsessiva
dc.subject.classificationDiagnòstic per la imatge
dc.subject.otherObsessive-compulsive disorder
dc.subject.otherDiagnostic imaging
dc.titleCortical Abnormalities Associated With Pediatric and Adult Obsessive-Compulsive Disorder: Findings From the ENIGMA Obsessive-Compulsive Disorder Working Group
dc.typeinfo:eu-repo/semantics/article
dc.typeinfo:eu-repo/semantics/acceptedVersion

Fitxers

Paquet original

Mostrant 1 - 1 de 1
Carregant...
Miniatura
Nom:
687066.pdf
Mida:
1.32 MB
Format:
Adobe Portable Document Format